Research & Clinical Trials – Page 2
-
news
Research & Clinical TrialsSellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on… -
news
Research & Clinical TrialsCARD Clinic to Release New Asbestos Research in 2024
The Center for Asbestos Related Disease has begun work on a series of new research articles scheduled to be released throughout 2024. The content… -
news
Research & Clinical TrialsPolaris Submits Application for New Mesothelioma Treatment
Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application… -
news
Research & Clinical TrialsPacific Heart, Lung & Blood Institute Is Dissolving
The Pacific Heart, Lung & Blood Institute in Los Angeles, California, will be permanently closing after more than two decades of work to develop… -
news
Research & Clinical TrialsTrial Shows Keytruda With Chemotherapy Superior to Chemo Alone
Results of a new phase 3 clinical trial published in the Journal of Clinical Oncology indicate that a chemoimmunotherapy regimen combining chemotherapy with immunotherapy… -
news
Research & Clinical TrialsStudy Finds Link Between Asbestos Exposure and Autoimmune Conditions
Asbestos is widely known as an occupational hazard, but emerging evidence suggests that prolonged exposure to environmental asbestos could lead to severe autoimmune… -
news
Research & Clinical TrialsMesothelioma Immunotherapy Receives Orphan Drug Designation
A novel therapy for mesothelioma has been given orphan drug designation by the U.S. Food and Drug Administration. Avenge Bio, a biotechnology company working… -
news
Research & Clinical TrialsResearchers Use Marine Bacteria to Reduce Asbestos Toxicity
Researchers from the University of Pennsylvania’s Department of Earth and Environmental Science have found that bacteria from extreme marine environments may potentially detoxify asbestos. -
news
Research & Clinical TrialsPhase 3 Keytruda, Chemotherapy Mesothelioma Trial Shows Promising Results
Pharmaceutical company Merck says use of its immunotherapy drug Keytruda in conjunction with chemotherapy increases the survival rate for people with advanced pleural… -
news
Research & Clinical TrialsNew UMD Study Shows How Mesothelioma Can Spread
Researchers at the University of Maryland are getting a better idea of why mesothelioma takes decades to develop in the body. In a…